Nasdaq
$108.00▲ 0.11%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $4.97BShares out 46.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
60- 5d agoAfter-hours26.10.20 08:354Ownership#●●●#●●●
BillionToOne, Inc.
Insider Thomas P. Lynch of BillionToOne, Inc. reported a change in beneficial ownership of securities as of October 13, 2026. This filing is a Form 4 statement submitted to the SEC regarding the insider's equity holdings.…more
$108.00+0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16After-hours26.10.17 08:004Ownership
BillionToOne, Inc.
BillionToOne, Inc. insider Atay Oguzhan reported a change in beneficial ownership of securities effective October 14, 2026. This filing serves as a standard disclosure of insider equity transactions via Form 4.…more
$108.00+0.11%vs prev closeView filingShare - 10.15After-hours26.10.16 05:33144Ownership
BillionToOne, Inc.
Insider Atay Oguzhan of BillionToOne, Inc. has filed Form 144 with the SEC to report the proposed sale of company securities. This filing serves as a formal notification of the insider's intent to dispose of shares.…more
$108.00+0.11%vs prev closeView filingShare
59 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.14Pre-market26.10.14 21:05#●●●#●●●
BillionToOne to Report Q3 2026 Financial Results on November 4
BillionToOne announced it will release its third-quarter 2026 financial results after market close on November 4, 2026. The company will also host a conference call to discuss the quarterly performance with investors.…more
$108.00+0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.7Pre-market26.10.07 20:00
●●●●●●●● ●●●●● ●●●●●●
A new peer-reviewed study shows that BillionToOne’s tissue-free Northstar Response assay performs on par with or better than traditional tumor-informed testing. This liquid biopsy method allows for effective cancer treatment monitoring without the need for prior tissue sequencing.…more
$108.00+0.11%vs prev close - 8.18Regular26.08.19 01:16
●●●●●●●● ●●●●● ●●●●●●
BillionToOne announced the publication of a study validating the performance of cell-free DNA testing in a general-risk pregnancy population. The findings provide significant evidence supporting the routine use of cfDNA fetal risk assessment in clinical practice.…more
$108.00+0.11%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report